@Davisite. Look at MSB, in their phase 2 trial the data was promising for weaning off the LVAD, but in Phase 2b, they couldn’t replicate it. They didn’t even include
any results of echocardiogram done in patients - unbelievable! That is unforgivable, to note release results of echocardiogram sin a trial for Heart failure.
if you read the objective of phase 2a trial, it will become quit clear why thier stock crashed.
hope thier phase 3 trial has better results as it would be life changing for many patients with endstage heart failure who die waiting transplants.
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-561
-
- There are more pages in this discussion • 478 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.001(4.76%) |
Mkt cap ! $18.04M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.0¢ | $12.00K | 600.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 972631 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 199783 | 1 |
View Market Depth
| Last trade - 14.33pm 01/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |